Back

Moderate walking speed predicts 3-years hospitalisation in hypertensive patients with cardiovascular disease

20 April 2018 (09:00 - 09:15)
Organised by:
Congress Presentation Part of: Young investigator award session III - Exercise Basic & Translational Research (EBTR) Secondary Prevention EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Carlotta Merlo

University of Ferrara, Ferrara (Italy)

5 More presentations in this session

Presentation thumbnail
What is best for women? The effects of aerobic interval training and moderate-intensity continuous exercise on physical and mental health in women with heart disease
Professor J. Reed (Ottawa, CA)
Abstract
Presentation thumbnail
The relation between insulin resistance on longitudinal changes in left ventricular structure and function in a general population.
Mr N. Cauwenberghs (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Increased heart rate does not explain the cardiac Troponin increase following strenous exercise - the NEEDED 2014 advanced heart rate monitor substudy
Doctor M. Bjorkavoll-Bergseth (Stavanger, NO)
Abstract Slides Video
Presentation thumbnail
Predictors of response to exercise training in patients with coronary artery disease: a subanalysis of the SAINTEX-CAD study
Doctor I. Witvrouwen (Edegem, BE)
Abstract
Presentation thumbnail
Effects of cyborg-type robot suit HAL on cardiopulmonary burden during exercise in normal subjects
Doctor Y. Pak (Tsukuba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Young investigator award session III - Exercise Basic & Translational Research (EBTR)

The Event

Event poster

EuroPrevent 2018

20 April 2018 09:00 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources